Review
Aug 2026
Naringin and hepatic metabolic dysfunction in diabetes and metabolic syndrome: mechanisms and therapeutic perspectives.
Current evidence supports NAR as a promising multitarget therapeutic candidate for hepatic metabolic dysfunction; however, further studies addressing pharmacological optimization and clinical translation are required to fully establish its therapeutic potential.
María Paula Combina Herrera, Gabriela Natalia Ávila Sabattini, G. Picotto et al.
· European Journal of Pharmaco... · 0 citations